Novo Nordisk A/S Common Stock (NVO)

Deferred Revenue

kr 0.00

Quarterly · Period ending: · DKK

NVO logo

NVO Deferred Revenue

Latest reportedkr 0.00 DKK
NVO Quarterly Deferred Revenue · DKK (kr 0.00 → kr 0.00)
High-resolution chart · PNG

NVO deferred revenue history

Quarterly · DKK. Dates are reporting period ends; fiscal years can differ from calendar years.

Novo Nordisk A/S Common Stock Deferred Revenue — Quarterly (DKK)
Period endingDeferred Revenue (DKK)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
39,545,000,000
35,325,000,000
32,431,000,000
44,869,000,000
29,296,000,000
28,128,000,000
24,104,000,000
39,443,000,000
26,458,000,000
23,576,000,000
26,215,000,000
38,618,000,000
23,225,000,000
21,704,000,000
21,425,000,000
33,491,000,000
20,032,000,000
18,736,000,000
17,280,000,000
25,412,000,000
14,030,000,000
10,237,000,000
10,432,000,000
2,983,000,000
12,721,000,000
12,022,000,000
10,822,000,000
17,231,000,000
13,218,000,000
10,781,000,000
9,302,000,000
7,111,000,000
8,160,000,000
7,680,000,000
6,613,000,000
5,896,000,000
1,271,000,000
613,000,000
661,000,000
701,000,000
1,133,000,000
755,000,000
3,390,000,000
80,238,000
0
0
0
122,736,000
0
0
0
0
0
0
0
0
0
0
0
109,756,200
0
0
0
810,039,900
1,323,528,030
0
0
0
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.